Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

P Kong, ZY Cui, XF Huang, DD Zhang… - Signal transduction and …, 2022 - nature.com
Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and
nontraditional risk factors. Genome-wide association combined with clonal lineage tracing …

WNT signaling in cardiac and vascular disease

S Foulquier, EP Daskalopoulos, G Lluri… - Pharmacological …, 2018 - ASPET
WNT signaling is an elaborate and complex collection of signal transduction pathways
mediated by multiple signaling molecules. WNT signaling is critically important for …

[HTML][HTML] Regulation of innate immunity by Nrf2

D van der Horst, ME Carter-Timofte… - Current Opinion in …, 2022 - Elsevier
The transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) has been mainly
investigated as a regulator of redox homeostasis. However, research over the past years …

Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease

L Badimon, T Padró, G Vilahur - European Heart Journal: Acute …, 2012 - academic.oup.com
Atherosclerosis is the underlying reason for nearly all causes of coronary artery disease and
peripheral arterial disease and many cases of stroke. Atherosclerosis is a systemic …

Lipoprotein receptor signalling in atherosclerosis

C Mineo - Cardiovascular research, 2020 - academic.oup.com
The founding member of the lipoprotein receptor family, low-density lipoprotein receptor
(LDLR) plays a major role in the atherogenesis through the receptor-mediated endocytosis …

PCSK9 and LRP5 in macrophage lipid internalization and inflammation

L Badimon, A Luquero, J Crespo, E Peña… - Cardiovascular …, 2021 - academic.oup.com
Aims Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood
cholesterol levels and chronic inflammation. Low-density lipoprotein receptors (LDLR) play …

PCSK9 functions in atherosclerosis are not limited to plasmatic LDL-cholesterol regulation

A Luquero, L Badimon, M Borrell-Pages - Frontiers in Cardiovascular …, 2021 - frontiersin.org
The relevance of PCSK9 in atherosclerosis progression is demonstrated by the benefits
observed in patients that have followed PCSK9-targeted therapies. The impact of these …

Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

RAK Srivastava - Molecular and cellular biochemistry, 2018 - Springer
Coronary artery disease, the leading cause of death in the developed and developing
countries, is prevalent in diabetes mellitus with 68% cardiovascular disease (CVD)-related …

Targeting the canonical WNT/β-catenin pathway in cancer treatment using non-steroidal anti-inflammatory drugs

A Vallée, Y Lecarpentier, JN Vallée - Cells, 2019 - mdpi.com
Chronic inflammation and oxidative stress are common and co-substantial pathological
processes accompanying and contributing to cancers. Numerous epidemiological studies …

Wnt signalling in smooth muscle cells and its role in cardiovascular disorders

C Mill, SJ George - Cardiovascular research, 2012 - academic.oup.com
Vascular smooth muscle cells (SMCs) are the major cell type within blood vessels. SMCs
exhibit low rates of proliferation, migration, and apoptosis in normal blood vessels. However …